4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-19-020742
EVP, Research and Development gave up 960 shares (to pay taxes)
- EVP, Research and Development acquired 1,126 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ehlers Michael D EVP, Research and Development | 2019-06-01 | Shares withheld for taxes | −460 | $219.29 | $100,873 | 7,399.22 | D: show line 1 in the form |
| Ehlers Michael D EVP, Research and Development | 2019-06-01 | Option exercise | +1,126 | 8,525.22 | D: show line 2 in the form | ||
| Ehlers Michael D EVP, Research and Development | 2019-06-01 | Shares withheld for taxes | −500 | $219.29 | $109,645 | 8,025.22 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ehlers Michael D EVP, Research and Development | 2019-06-01 | Option exercise · Restricted Stock Unit | −1,126 | $0.00 | 2019-06-01 | 1,126 | 1,376 | D: show line 4 in the form | ||
| Ehlers Michael D EVP, Research and Development | 2019-06-01 | Other disposition · Restricted Stock Unit | −1,376 | $0.00 | 2019-06-01 | 1,376 | 0 | D: show line 5 in the form |
Loading xslF345X03/form4.xml…